A

NCCN Clinical Practice Guidelines for Treating GIST

By Andrea Napolitano
91 views
April 11, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
22:07
Total Health

2024 Update in Sarcomas

Feat. D. Portnoy
18:46
OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard
19:40
Warren Chow

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

15:45
i3 Health

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

Feat. S. Patel, B. Ruben, K. Polson
10:55
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Feat. R. Jones
21:12
ISCO - International School of Clinical Oncology

What Is New in Treatment of Soft Tissue and Bone Sarcoma

Feat. S. Stacchiotti
18:44
2023 West Oncology Conference

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

Feat. B. Van Tine
09:02
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA…

Feat. Y. Chae
07:29
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized Phase 2 Trial in Metastatic So…

Feat. B. Van Tine
56:31
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Sarcoma Updates

Feat. M. Wagner
12:08
University of Miami Sylvester Comprehensive Cancer Center

Active Surveillance vs. Active Treatment for Desmoid Tumor: An Exper…

Feat. G. D'Amato
10:48
Insights from 2024 ASCO® GI Annual Meeting

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Feat. J. Zalcberg
13:53
Robin Jones

Desmoid Tumors: Who, When, and How to Treat?

09:01
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Results From the MEDISARC Phase II Study o…

Feat. V. Grünwald
11:03
Insights from 2024 ASCO® GI Annual Meeting

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripreti…

Feat. J. Zalcberg
21:21
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Radiation Therapy in Metastatic Sarcoma -…

Feat. N. Laack
07:00
Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Rip…

Feat. J. Blay
12:51
R. Lor Randall

Desmoid Tumors: The Malignant Non-Malignancy

08:25
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Efficacy & Safety From MANTRA Study - …

Feat. R. Jones
12:21
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Single-Arm, Open-Label Phase 2 Trial of…

Feat. B. Wilky